Table 2.
Patient characteristics of 109 SLND
| Age, years (range) | Median | 63.5 | (28–89) |
| Grading, uterus-specimen | G1 | 57 | 52% |
| G2 | 30 | 28% | |
| G3 | 22 | 20% | |
| Histopathological type | |||
| Type I | 99 | 91% | |
| Type II | 10 | 9% | |
| Serous | 6 | ||
| Clear cell | 1 | ||
| Carcinosarcoma | 3 | ||
| Uterine risk factors | Low risk | 53 | 49% |
| Intermediate risk | 25 | 23% | |
| High-intermediate risk | 13 | 12% | |
| High risk | 18 | 17% | |
| Nodal involvement | Low risk | 0 | 0% |
| Intermediate risk | 3 | 12% | |
| High-intermediate risk | 7 | 54% | |
| High risk | 11 | 61% | |
| Final FIGO stage | IA | 60 | 55% |
| IB | 23 | 21% | |
| II | 5 | 5% | |
| IIIC1 | 10 | 9% | |
| IIIC2 | 5 | 5% | |
| IIIA | 1 | 1% | |
| IVB | 5 | 5% | |